MX9705709A - Uso de compuestos de tiazepina, oxazepina y diazepina para inhibir el vih, virus del herpes y suprimir el sistema inmunologico. - Google Patents

Uso de compuestos de tiazepina, oxazepina y diazepina para inhibir el vih, virus del herpes y suprimir el sistema inmunologico.

Info

Publication number
MX9705709A
MX9705709A MX9705709A MX9705709A MX9705709A MX 9705709 A MX9705709 A MX 9705709A MX 9705709 A MX9705709 A MX 9705709A MX 9705709 A MX9705709 A MX 9705709A MX 9705709 A MX9705709 A MX 9705709A
Authority
MX
Mexico
Prior art keywords
herpesvirus
coumpounds
thiazepine
oxazepine
diazepine
Prior art date
Application number
MX9705709A
Other languages
English (en)
Inventor
Stephen Joseph Gracheck
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MX9705709A publication Critical patent/MX9705709A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Benzotiofeno, benzofuran e indole-tiazepinones, axazepinones y diazepinones son efectivos agentes terapéuticos para tratar enfermedades vírales, incluso aquellas causadas por el virus del herpes y el VIH.
MX9705709A 1995-03-22 1996-01-26 Uso de compuestos de tiazepina, oxazepina y diazepina para inhibir el vih, virus del herpes y suprimir el sistema inmunologico. MX9705709A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/408,431 US5612330A (en) 1994-03-07 1995-03-22 Methods for inhibiting and controlling viral growth
PCT/US1996/001098 WO1996029077A1 (en) 1995-03-22 1996-01-26 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system

Publications (1)

Publication Number Publication Date
MX9705709A true MX9705709A (es) 1997-10-31

Family

ID=23616271

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9705709A MX9705709A (es) 1995-03-22 1996-01-26 Uso de compuestos de tiazepina, oxazepina y diazepina para inhibir el vih, virus del herpes y suprimir el sistema inmunologico.

Country Status (11)

Country Link
US (2) US5612330A (es)
EP (1) EP0817635B1 (es)
JP (1) JPH11502814A (es)
AT (1) ATE269084T1 (es)
CA (1) CA2211179A1 (es)
DE (1) DE69632726T2 (es)
DK (1) DK0817635T3 (es)
ES (1) ES2222477T3 (es)
MX (1) MX9705709A (es)
PT (1) PT817635E (es)
WO (1) WO1996029077A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612330A (en) * 1994-03-07 1997-03-18 Warner-Lambert Company Methods for inhibiting and controlling viral growth
US6218103B1 (en) * 1997-04-16 2001-04-17 Arch Development Corporation Herpes simplex virus US3 and ICP4 as inhibitors of apoptosis
CA2227688C (en) 1998-01-16 2007-07-31 James W. Critchfield Methods and compositions for inhibition of viral replication
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
AU2001281142A1 (en) * 2000-08-16 2002-02-25 Japan Tobacco Inc. Diazepinones as antiviral agents
AP2006003791A0 (en) * 2004-05-17 2006-10-31 Tibotec Pharm Ltd 1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
PT1799696E (pt) 2004-09-17 2009-02-16 Idenix Pharmaceuticals Inc Fosfoindoles como inibidores de hiv
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
PE20080993A1 (es) 2006-06-27 2008-10-06 Takeda Pharmaceutical Compuestos ciclicos fusionados como moduladores del receptor gpr40
CA2664396A1 (en) 2006-09-29 2008-04-10 Idenix Pharmaceuticals, Inc. Enantiomerically pure phosphoindoles as hiv inhibitors
CA2722211C (en) * 2008-04-24 2017-02-14 Indena S.P.A. Compositions for the treatment of vaginal infections with chronic inflammation
WO2012078859A2 (en) * 2010-12-09 2012-06-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Protein kinase d inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013641A (en) * 1975-10-08 1977-03-22 Xerox Corporation Indolobenzoxazepines
AU5883794A (en) * 1993-01-20 1994-08-15 A. Menarini Industrie Farmaceutiche Riunite S.R.L. Diazepin derivatives and antiviral compositions
US5489586A (en) * 1994-03-07 1996-02-06 Warner-Lambert Company Method for treating inflammatory disease in humans
US5612330A (en) * 1994-03-07 1997-03-18 Warner-Lambert Company Methods for inhibiting and controlling viral growth

Also Published As

Publication number Publication date
EP0817635A1 (en) 1998-01-14
US5612330A (en) 1997-03-18
JPH11502814A (ja) 1999-03-09
PT817635E (pt) 2004-10-29
DE69632726D1 (de) 2004-07-22
WO1996029077A1 (en) 1996-09-26
DE69632726T2 (de) 2004-10-14
US5703069A (en) 1997-12-30
ES2222477T3 (es) 2005-02-01
CA2211179A1 (en) 1996-09-26
EP0817635B1 (en) 2004-06-16
DK0817635T3 (da) 2004-09-27
ATE269084T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
ZA971937B (en) Combinations for treatment of proliferative diseases.
DE69621830D1 (en) Alpha-substituierte arylsulphonamidohydroxamsaüre als tnf-alpha und matrix-metalloproteinase-inhibitoren
HRP980222B1 (en) Pyrazolopyrimidinones for the treatment of sexual disfunction
MX9705709A (es) Uso de compuestos de tiazepina, oxazepina y diazepina para inhibir el vih, virus del herpes y suprimir el sistema inmunologico.
AP9801346A0 (en) Xanthone analogs for the treatment of infectious diseases
EP1010435A4 (en) PREPARATIONS OF NANOCAPSULES FOR THE TREATMENT OF INTRA-ARTICULAR DISEASES
EP0869801A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
IL117826A (en) Effluent treatment system
EP0689455A4 (en) THERAPEUTIC STRATEGIES FOR THE TREATMENT OF IMMUNO-INFECTIOUS GROUP VIRAL INFECTIONS
IL109280A0 (en) Neurotrophins for treatment of depression
GB9515279D0 (en) Improved therapeutic agents
PL336579A1 (en) Treatment of diseases associated with cytokinins
TW327171B (en) 2-heteroaryl-5 for prevention or treatment of HIV infection
ZA971600B (en) Treatment of macular edema.
IL128351A0 (en) Pharmaceutical composition for treating viral diseases
HRP960045B1 (en) Combination therapy for hiv infection
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
CY2339B1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections.
HUP0100365A3 (en) Combination therapy for the treatment of aids
IL130160A0 (en) Inactivation of HIV co-receptors as therapy for HIV infection
ZA991785B (en) Therapeutic treatment for cytomegalovirus infection.
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
SI0817635T1 (en) Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees